Sveva Castelli

Berlin, BE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

A pilot study combining primary busulfan-based haploidentical stem cell transplantation with GD2 antibody to treat high-risk neuroblastoma.

A pilot study combining primary busulfan-based haploidentical stem cell transplantation with GD2 antibody to treat high-risk neuroblastoma.

Journal: Bone marrow transplantation

Published: January 18, 2026

Current treatment strategies for first relapse of high-risk neuroblastoma.

Current treatment strategies for first relapse of high-risk neuroblastoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 16, 2025

YAP1 Enhances Mesenchymal-Type Gene Expression in Human Adrenergic-Type Neuroblastoma Cells.

YAP1 Enhances Mesenchymal-Type Gene Expression in Human Adrenergic-Type Neuroblastoma Cells.

Journal: Cancers

Published: December 10, 2025

Improved Outcomes for Older Children, Adolescents, and Young Adults With Neuroblastoma in the Post-Immunotherapy Era: An Updated Report From the International Neuroblastoma Risk Group.

Improved Outcomes for Older Children, Adolescents, and Young Adults With Neuroblastoma in the Post-Immunotherapy Era: An Updated Report From the International Neuroblastoma Risk Group.

Journal: Pediatric blood & cancer

Published: September 23, 2025

Correction: GPOH Guidelines for Diagnosis and First-line Treatment of Patients with Neuroblastic Tumors, update 2025.

Correction: GPOH Guidelines for Diagnosis and First-line Treatment of Patients with Neuroblastic Tumors, update 2025.

Journal: Klinische Padiatrie

Published: June 05, 2025

GPOH Guidelines for Diagnosis and First-line Treatment of Patients with Neuroblastic Tumors, update 2025.

GPOH Guidelines for Diagnosis and First-line Treatment of Patients with Neuroblastic Tumors, update 2025.

Journal: Klinische Padiatrie

Published: May 09, 2025

Management of Busulfan-Induced Lung Injury in Pediatric Patients with High-Risk Neuroblastoma.

Management of Busulfan-Induced Lung Injury in Pediatric Patients with High-Risk Neuroblastoma.

Journal: Journal of clinical medicine

Published: September 11, 2024

Prospective (e-diary) vs retrospective (ARIA) measures of severity in allergic rhinoconjunctivitis: An observational compatibility study.

Prospective (e-diary) vs retrospective (ARIA) measures of severity in allergic rhinoconjunctivitis: An observational compatibility study.

Journal: Allergy

Published: May 31, 2022

Heterogeneous validity of daily data on symptoms of seasonal allergic rhinitis recorded by patients using the e-diary AllergyMonitor®.

Heterogeneous validity of daily data on symptoms of seasonal allergic rhinitis recorded by patients using the e-diary AllergyMonitor®.

Journal: Clinical and translational allergy

Published: August 19, 2021

Validation Parameters of Patient-Generated Data for Digitally Recorded Allergic Rhinitis Symptom and Medication Scores in the @IT.2020 Project: Exploratory Study.

Validation Parameters of Patient-Generated Data for Digitally Recorded Allergic Rhinitis Symptom and Medication Scores in the @IT.2020 Project: Exploratory Study.

Journal: JMIR mHealth and uHealth

Published: June 23, 2021

@IT2020: An innovative algorithm for allergen immunotherapy prescription in seasonal allergic rhinitis.

@IT2020: An innovative algorithm for allergen immunotherapy prescription in seasonal allergic rhinitis.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Published: November 04, 2020

Adherence to Prescribed E-Diary Recording by Patients With Seasonal Allergic Rhinitis: Observational Study.

Adherence to Prescribed E-Diary Recording by Patients With Seasonal Allergic Rhinitis: Observational Study.

Journal: Journal of medical Internet research

Published: October 10, 2019

Showing 1-12 of 15

Last Updated: 09/26/2026